Mariner, LLC Catalent, Inc. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Mariner, LLC holds 4,772 shares of CTLT stock, worth $289,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,772

Previous 4,481 6.49%

Holding current value

$289,899

Previous $251,000 15.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$56.16 - $60.96 $16,342 - $17,739	291 Added 6.49%	4,772 $289,000
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $39,274 - $41,795	-733 Reduced 14.06%	4,481 $251,000
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $215,055 - $302,270	-5,053 Reduced 49.22%	5,214 $294,000
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $90,490 - $130,954	-2,812 Reduced 21.5%	10,267 $461,000
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $91,626 - $104,064	2,073 Added 18.84%	13,079 $595,000
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $383,052 - $808,666	-12,023 Reduced 52.21%	11,006 $477,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $45,212 - $73,888	995 Added 4.52%	23,029 $1.51 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $332,444 - $650,592	8,032 Added 57.36%	22,034 $992,000
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $295,518 - $461,900	-4,084 Reduced 22.58%	14,002 $1.01 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $426,233 - $557,476	4,888 Added 37.04%	18,086 $1.94 Million
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $1.24 Million - $1.64 Million	13,198 New	13,198 $1.46 Million
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $332,577 - $406,872	-7,009 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $9,736 - $13,444	-248 Reduced 3.42%	7,009 $380,000
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $216,548 - $318,727	7,257 New	7,257 $295,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account